Promising immunotherapy drug leads patients with cancerous GTD into remission – News-Medical.net
http://www.newsgram.com/ |
Promising immunotherapy drug leads patients with cancerous GTD into remission
News-Medical.net Three out of four patients with the cancerous forms of gestational trophoblastic disease (GTD) went into remission after receiving the immunotherapy drug pembrolizumab in a clinical trial carried out by researchers at Imperial College London. The trial … Immunotherapy Drug May Treat Rare Pregnancy Cancer, Says Research |
